Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2000
11/15/2000CN1273112A Repellent antipruritic liquid for mosquito bite
11/15/2000CN1273111A Ointment for treating skin tinea
11/15/2000CN1273099A Exterior-applied medicine for treating scald and its preparing process
11/15/2000CN1273095A Exterior-applied medicine for treating dermatopathy and its preparing process
11/15/2000CN1273088A Amino substituted hydroxy-diphenylone as light stability ultraviolet fitering agent used in cosmetic and pharmaceutical preparation
11/15/2000CN1058499C 16-substituted-4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors
11/15/2000CN1058406C External-use Chinese medicine preparation for psoriasis
11/15/2000CN1058397C Wound sticker and its preparing method
11/15/2000CN1058395C Inhalant for prevention and treatment of baldness
11/14/2000US6147255 Topical and systemic treatment of dermatological complaints associated with keratinization disorder which has effect on differentiation and on proliferation
11/14/2000US6147250 Treating diseases mediated by vascular cell adhesion molecule-1, including cardiovascular and inflammatory diseases; succinobucol
11/14/2000US6147224 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147120 Synergistic antimicrobial skin washing compositions
11/14/2000US6147096 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
11/14/2000US6147077 2R,4S-hydroxyitraconazole isomers
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6147061 Antiarthritic agents; anticancer agents; oral diseases
11/14/2000US6147053 Combination containing growth factors and polyelectrolytes
11/14/2000US6146649 Photobluing/whitening-resistant cosmetic/dermatological compositions comprising TiO2 pigments and deformable hollow particulates
11/14/2000US6146636 Substance P antagonists comprising rosaceae plant extracts
11/14/2000US6146626 Mixtures of purified enzymes from clostridium histolyticum, comprising collagenase with hexapeptide as a substrate, collagenase using azocoll as substrate and elastase, used as wound healing agent
11/09/2000WO2000066754A1 Protein c derivatives
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066631A1 SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS FOR TGFβ¿1?
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066599A1 Antioxidative vitamin b6 analogs
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066172A1 Non-aqueous liquid shampoo composition
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066131A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066111A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066100A2 2r,4s-hydroxyitraconazole isomers
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066078A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000019989A3 Use of catechol derivatives as proteinase inhibitors
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371653A1 Antioxidative vitamin b6 analogs
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371034A1 Non-aqueous liquid shampoo composition
11/09/2000CA2370304A1 Specific antibodies and antibody fragments for tgf.beta.1
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369357A1 2r,4s-hydroxyitraconazole isomers
11/09/2000CA2338799A1 Protein c derivatives
11/09/2000CA2336362A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1050298A2 Composition for treating and/or ameliorating the diseases of dandruff, seborrheic dermatitis, psoriasis and eczema and symptoms thereof
11/08/2000EP1050296A1 Composition containing at least a bicyclic aromatic compound and at least a lipopholic sunscreen, and its uses
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049634A1 Methods and compositions for treating dermatoses
11/08/2000EP1049483A1 Method for treating inflammatory diseases using heat shock proteins
11/08/2000EP1049471A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
11/08/2000EP1049468A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP1049378A2 An antimicrobial composition
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272783A Dermatological compositions
11/08/2000CN1272381A Shaoshangfu sukang ointment for curing burn
11/08/2000CN1272375A Acne-eliminating capsule and liniment for curing acnes
11/08/2000CN1272361A Bromhidrosis-removing powder
11/08/2000CN1058180C Plaster for curing burn and scald and its preparation method
11/08/2000CN1058155C Medicinal liquid for curing bromhidrosis
11/08/2000CN1058151C Medicine for curing burn and scald
11/07/2000US6143910 Methods for preparation and use of 1α, 24(S) -dihydroxy vitamin D2
11/07/2000US6143906 Ascorbyl sorbates
11/07/2000US6143793 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
11/07/2000US6143775 Physical form of zafirlukast; asthma
1 ... 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 ... 1065